C. May

发表

Cerebrospinal fluid production is reduced in healthy aging

J. Kaye, S. Rapoport, M. Schapiro, 1990, Neurology.

Alzheimer's disease

S. Rapoport, P. Whitehouse, B. Eipper, 1987, Neurology.

Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features

J. Kaye, S. Rapoport, S. Milstien, 1988, Neurology.

Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.

S. Rapoport, M. Schapiro, C. May, 2005, Archives of neurology.

Cerebrospinal fluid monoamines in Down's syndrome adults at different ages.

J. Haxby, S. Rapoport, M. Schapiro, 2008, Journal of mental deficiency research.

CSF α‐MSH in dementia of the Alzheimer type

J. Kaye, S. Rapoport, R. Friedland, 1988, Neurology.

Quantitative analysis of polyols in human plasma and cerebrospinal fluid.

S. Rapoport, J. Degeorge, C. May, 1989, Journal of chromatography.

The viral hypothesis of Alzheimer's disease. Absence of antibodies to lentiviruses.

R. Friedland, C. May, J. Dahlberg, 1990, Archives of neurology.

Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.

L. Thal, S. Rapoport, I. Litvan, 1991, Journal of neurology, neurosurgery, and psychiatry.

Cerebrospinal fluid gradients of acetylcholinesterase and butyrylcholinesterase activity in healthy aging

J. Kaye, S. Rapoport, J. Atack, 1990, Neurochemistry International.

Cerebrospinal fluid cholinesterases in aging and in dementia of the alzheimer type

J. Kaye, S. Rapoport, J. Atack, 1988, Annals of neurology.

α-Melanocyte-Stimulating Hormonelike Immunoreactivity Is Increased in Cerebrospinal Fluid of Patients With Parkinson's Disease

M. Albert, J. Kaye, S. Rapoport, 1988 .

Lumbar cerebrospinal fluid choline in healthy aging and in Down's syndrome.

J. Haxby, J. Haxby, S. Rapoport, 1990, Archives of neurology.

Cerebrospinal fluid concentrations of corticotropin‐releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

S. Rapoport, G. Chrousos, P. Gold, 1987, Neurology.

Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.

J. Kaye, S. Rapoport, M. Beal, 1988, Archives of neurology.

Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.

J. Calabrese, D. Rubinow, R. Post, 1991, The Journal of clinical endocrinology and metabolism.

Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease.

T. Sunderland, W. Kaye, W. Berrettini, 1988, Neuropsychobiology.

Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease

J. Kaye, S. Rapoport, S. Milstien, 1988, Annals of neurology.

CSF and serum concentrations of albumin and IgG in Alzheimer's disease

S. Rapoport, J. Luxenberg, J. Atack, 1987, Neurobiology of Aging.

Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.

C. Grady, J. Haxby, S. Rapoport, 1987, Journal of neurology, neurosurgery, and psychiatry.

the Alzheimer type . twins discordant for dementia of and cognition in monozygotic Cerebral metabolism , anatomy ,

C. Grady, J. Haxby, S. Rapoport, 2022 .

Commentary on antemortem markers of Alzheimer's disease

C. Grady, S. Rapoport, J. Atack, 1986, Neurobiology of Aging.